Global Gene Corp Pte Ltd
| Private | |
| ISIN | 🆔 |
| Industry | Genomics |
| Founded 📆 | 2013 in Boston, United States |
| Founder 👔 | Dr. Saumya Jamuar Dr. Jonathan Picker |
| Headquarters 🏙️ | , Cambridge , England |
Area served 🗺️ | United Kingdom, United States, Singapore, India |
| Members | |
Number of employees | |
| 🌐 Website | globalgenecorp.com |
| 📇 Address | |
| 📞 telephone | |
Global Gene Corp is a genomics company that specialises in collecting data from under-explored patient populations, with a current focus on gathering genetic information of people of Indian descent.[1] The company analyses patients’ DNA in order to find individualized treatment, both as a service for individuals and to collect aggregate data for researchers. Currently based in the UK, the company was founded in 2013 by Dr. Saumya Jamuar, Harvard Medical School geneticist Dr. Jonathan Picker, and current CEO Sumit Jamuar.[2][3][4][5]
History[edit]
The company was founded in 2013 and was the brain-child of two Harvard Medical School doctors who joined forces with two business executives.[2] According to co-founder Jamuar, the idea for the business came about when the group realized that 60% of the world’s population made up less than 1% of the genetic data that had been collected in the mapping of the human genome, as most of the genetic mapping had been done on people of European descent.[4]
The company began with a focus on mapping the genome of people of Indian descent, whose DNA as of 2017 made up only approximately 0.2% of the global genetic databases, despite the nation of India making up 20% of the world’s population. The company has plans to expand its research to Africa and other parts of Asia in the future.[6]
By July of 2016, the company had gathered more than 10,000 DNA samples.[2]
In February 2017, the announced that Dr Yaron Turpaz, former CIO of Human Longevity Inc, had joined the company as Chief Data and Technology Officer.[7][8]
In November 2017 the company announced its collaboration with the Ohio State University Comprehensive Cancer Center in order to research rare cancers in South Asian and Indian populations.[1]
Similar Projects[edit]
Similar projects to expand genetic mapping of different ethnic groups including Professor Carlos Bustamante’s Population Genomics and Global Health team, which focuses on mapping the genes of people from Latin America and the Carribean. The country of South Korea also has a similar project.[6]
See Also[edit]
- Sumit Jamuar, CEO of Global Gene Corp.
- Gene mapping
- Human Genome Project
References[edit]
- ↑ 1.0 1.1 "Global Gene Corp announces collaboration for cancer research in South Asian and Indian Populations". The Times of India. Cambridge, UK. 16 November 2017.
- ↑ 2.0 2.1 2.2 Woyke, Elizabeth (25 July 2016). "Taking Genomic Data Global". technologyreview.com. MIT Technology Review.
- ↑ "Leadership Tem". globalgenecorp.com. Global Gene Corp.
- ↑ 4.0 4.1 Isaac, Anna (20 February 2017). "Global Gene Corp chief: Building a UK base means access to the top talent". The Telegraph.
- ↑ Ram, Vidya (24 January 2018). "Three-nation project to close gaps in Indian gene data". The Hindu Business Line.
- ↑ 6.0 6.1 Arney, Kat (22 June 2017). "The power of a billion: India's genomics revolution". BBC.
- ↑ "Global Gene Corp taps Yaron Turpaz as new Chief Data & Technology Officer". The Times of India. New Delhi, India. 3 July 2017.
- ↑ "Former CIO of Human Longevity Joins Global Gene Corp". Front Line Genomics.
Global Gene Corp[edit]
This article "Global Gene Corp" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Global Gene Corp. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
